International Journal of Cancer · 2002 · 98 citations · 27 references
Life SciencesGeneticsOncologyCancer GeneticsCancer ImmunologyTumor ImmunologyHuman Leukocyte Antigen SystemMajor Histocompatibility ComplexMelanocytic TumorsTumor AntigensTumor ImmunopathologyTumor-associated AntigensAntigen Presentation LossHla Antigen ExpressionHla Antigen PresentationHla Class I MoleculesHla Gene ExpressionHla LossMajor Histocompatibility Complex Class I LossMutated Tumor Antigens
Alterations in the surface expression of HLA class I molecules have been described as a strategy of tumors to evade recognition by cytotoxic T cells. We detected complete loss of HLA class I antigen presentation for 2 tumor cell lines from 1 melanoma patient, the first originated from a regional lymph node lesion diagnosed simultaneously with the primary tumor and the second established 8 months later from a metastatic pleural effusion sample. Antigen presentation was not inducible with IFN-gamma but could be restored after transfection of tumor cells with b2m cDNA, indicating a defect in b2m expression. Analysis of the nature of this defect revealed that it originated from at least 2 mutational events affecting both copies of the b2m gene: a microdeletion of 498 bp in one b2m gene, including its entire exon 1, and a macrodeletion involving the entire copy of the second b2m gene. Microsatellite analysis pointed to the macrodeletion by demonstrating LOH for several specific markers on the long arm (q) of chromosome 15. Structural imbalance of 15q was verified by FISH. FISH studies also indicated the coexistence of a structurally abnormal variant of chromosome 15q with 2 apparently entire chromosomes 15q harboring the homozygous b2m microdeletion. Block of b2m expression in tumor cells builds a barrier to immunotherapy of cancer patients, and its early incidence should be of major consideration in the development and design of immunotherapeutic strategies.
27
Jan Paul Medema, Joan de Jong, Lucy T.C. Peltenburg et al. · Proceedings of the National Academy of Sciences · 2001 · 350 citations · Full text
Life Sciences, Immunology, Oncology +17
The β2-microglobulin gene is on chromosome 15 and not in the HL-A region
Peter N. Goodfellow, Elizabeth Jones, Veronica van Heyningen et al. · Nature · 1975 · 273 citations
A. Muñoz Serrano, Silvia Tanzarella, Ilaria Lionello et al. · International Journal of Cancer · 2001 · 241 citations · Full text
Life Sciences, Immunology, Oncology +17